explore -WSS

explore

author：knowledge 2025-09-27 21:55:59 - browse：24717

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Senate HELP committee spars over health care workforce policies

WSS

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

CDC advisers recommend seasonal use of Pfizer RSV shot

Second xenotransplant done with gene

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Intarcia’s device

Astellas still sees hope in its gene therapy after four deaths

knowledge

explore

focus

As demand for Covid shots wanes, Moderna seeks its next success

Gain of function research would be limited under House proposal

After affirmative action ruling, medical educators look to 'holistic review'

CommonSpirit Health keeps growing, even as it loses money

Malaria cases in Florida and Texas: Here’s what you need to know

Experts study whether long Covid risk adds up with each reinfection

Bright Health sells Medicare Advantage business to Molina

Emergency workers more likely to restrain Black patients: study

State Dept. review finds Biden bears some blame for Afghanistan failures

STAT Virtual Event: Putting AI to the Test

knowledge

FDA's Woodcock to retire early next year

Readout LOUD podcast: possible new ALS drug, artificial wombs

Hospitals look to new technology to keep health care workers safe

Childhood cancer progress stalls for Black, Hispanic kids: Report

Intarcia’s device

Emergency workers more likely to restrain Black patients: study

explore

entertainment

focus

Wikipedia